Dieser Abschnitt ist nur in englischer Sprache verfügbar.

Consolidated statement of changes in equity

January 1 – December 31

 

 

 

 

Attributable to shareholders of Sulzer Ltd

 

 

 

 

millions of CHF

 

Notes

 

Share capital

 

Retained earnings

 

Treasury shares

 

Cash flow hedge reserve

 

Currency translation adjustment

 

Total

 

Non-controlling interests

 

Total equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2025

 

 

 

0.3

 

2’095.2

 

–51.6

 

–3.2

 

–817.2

 

1’223.6

 

11.5

 

1’235.1

Comprehensive income for the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

292.8

 

 

 

 

 

 

 

292.8

 

1.9

 

294.7

- Cash flow hedges, net of tax

 

27

 

 

 

 

8.0

 

 

8.0

 

 

8.0

- Remeasurements of defined benefit plans, net of tax

 

7

 

 

25.9

 

 

 

 

25.9

 

 

25.9

- Equity investments at FVOCI – net change in fair value, net of tax

 

16

 

 

1.0

 

 

 

 

1.0

 

 

1.0

- Currency translation differences

 

 

 

 

 

 

 

–112.9

 

–112.9

 

–0.1

 

–113.1

Other comprehensive income

 

 

 

 

26.9

 

 

8.0

 

–112.9

 

–78.0

 

–0.1

 

–78.1

Total comprehensive income for the period

 

 

 

 

319.7

 

 

8.0

 

–112.9

 

214.8

 

1.8

 

216.6

Transactions with owners of the company:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of treasury shares to share plan participants

 

 

 

 

–11.6

 

11.6

 

 

 

 

 

 

Purchase of treasury shares

 

22

 

 

 

–18.9

 

 

 

–18.9

 

 

 

–18.9

Share-based payments

 

29

 

 

17.3

 

 

 

 

17.3

 

 

 

17.3

Dividends

 

22

 

 

–143.6

 

 

 

 

–143.6

 

–1.2

 

–144.7

Equity as of December 31, 2025

 

22

 

0.3

 

2’277.1

 

–58.6

 

4.8

 

–930.4

 

1’293.2

 

12.1

 

1’305.4

January 1 – December 31

 

 

 

 

Attributable to shareholders of Sulzer Ltd

 

 

 

 

millions of CHF

 

Notes

 

Share capital

 

Retained earnings

 

Treasury shares

 

Cash flow hedge reserve

 

Currency translation adjustment

 

Total

 

Non-controlling interests

 

Total equity

Equity as of January 1, 2024

 

 

 

0.3

 

1’979.5

 

–36.7

 

4.2

 

–852.0

 

1’095.4

 

3.2

 

1’098.6

Comprehensive income for the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

261.9

 

 

 

 

 

 

 

261.9

 

3.5

 

265.4

- Cash flow hedges, net of tax

 

27

 

 

 

 

–7.5

 

 

–7.5

 

 

–7.5

- Remeasurements of defined benefit plans, net of tax

 

7

 

 

0.8

 

 

 

 

0.8

 

 

0.8

- Equity investments at FVOCI – net change in fair value, net of tax

 

16

 

 

–4.9

 

 

 

 

–4.9

 

 

–4.9

- Currency translation differences

 

 

 

 

 

 

 

30.3

 

30.3

 

0.4

 

30.7

Other comprehensive income

 

 

 

 

–4.0

 

 

–7.5

 

30.3

 

18.7

 

0.4

 

19.1

Total comprehensive income for the period

 

 

 

 

257.8

 

 

–7.5

 

30.3

 

280.6

 

3.9

 

284.5

Transactions with owners of the company:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Changes in non-controlling interests

 

 

 

 

 

–3.2

 

 

 

 

–3.2

 

3.2

 

0.0

Transactions with non-controlling interests

 

3

 

 

–6.1

 

 

 

4.6

 

–1.5

 

1.5

 

0.0

Contribution from medmix

 

 

 

 

0.1

 

 

 

 

0.1

 

 

0.1

Allocation of treasury shares to share plan participants

 

 

 

 

–18.3

 

18.3

 

 

 

 

 

Purchase of treasury shares

 

22

 

 

 

–33.2

 

 

 

–33.2

 

 

–33.2

Share-based payments

 

29

 

 

12.7

 

 

 

 

12.7

 

 

12.7

Dividends

 

22

 

 

–127.3

 

 

 

 

–127.3

 

–0.3

 

–127.6

Equity as of December 31, 2024

 

22

 

0.3

 

2’095.2

 

–51.6

 

–3.2

 

–817.2

 

1’223.6

 

11.5

 

1’235.1